Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer

Fig. 2

Expression of lncRNAs and their m6A methylation levels in clinical tissue samples, and METTL14 protein expression. (A) The expression of lncRNAs MSTRG.292666.16 and MSTRG.292667.12 in NSCLC. * P < 0.05, compared with the para-NSCLC. (B) The m6A methylation levels of lncRNAs MSTRG.292666.16 and MSTRG.292667.12 in NSCLC. * P < 0.05, compared with the para-NSCLC. (C) The protein expression of METTL14 in the different cell lines by western blot. * P < 0.05, compared with the BEAS-2B cells; #P < 0.05, compared with the NCI-H460 cells; $P < 0.05, compared with the NCI-H1650 cells. (D) The cell transfection efficiency after transfected with si-METTL14 by determining the expression of METTL14. * P < 0.05, compared with the control cells; #P < 0.05, compared with the si-METTL14 cells. (E) The cell transfection efficiency after transfected with oe-METTL14 by determining the expression of METTL14. * P < 0.05, compared with the control cells; #P < 0.05, compared with the oe-METTL14 cells

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us